Articles skews more negative than necessary. Cleverly written soft bash. Plenty of folks here have seen Leronlimab work against Covid on loved ones first-hand. Article implies it doesn’t work and underscores the shady side of the company’s past while downplaying its enormous potential. I guess it’s just par for the course right now. We’ll have to contend with such efforts to pressure pps downwards for a while.